What is RDW‑SD (red cell distribution width standard deviation) and what does an abnormal result indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

RDW-SD: Definition and Clinical Significance

RDW-SD (Red Cell Distribution Width - Standard Deviation) is a hematological parameter measured in femtoliters (fL) that quantifies the absolute variation in red blood cell volume, with elevated values (>42-45 fL) serving as a powerful independent predictor of mortality and disease severity across multiple conditions, far beyond its traditional role in anemia diagnosis.

What RDW-SD Measures

RDW-SD represents the actual width of the red blood cell volume distribution curve at one standard deviation above and below the mean, expressed in femtoliters 1. Unlike RDW-CV (coefficient of variation), RDW-SD provides an absolute measurement of red cell size heterogeneity (anisocytosis) that is less affected by mean corpuscular volume 1.

Traditional Clinical Application

  • Anemia diagnosis: RDW-SD has been traditionally used alongside mean corpuscular volume (MCV) to differentiate types of anemia 2, 1
  • Iron deficiency: Low MCV with elevated RDW suggests iron deficiency, folate deficiency, or vitamin B12 deficiency 2
  • Genetic disorders: Elevated RDW-SD can indicate sideroblastic anemia, particularly in female carriers of X-linked sideroblastic anemia (XLSA) where two distinct red cell populations exist due to X-inactivation 3

Expanded Prognostic Applications

Cardiovascular Disease

RDW-SD functions as an independent risk factor for mortality in cardiovascular conditions, with cut-off values around 42-49 fL demonstrating strong predictive value 4, 5:

  • STEMI patients: Mean RDW-SD of 49.0 ± 4.6 fL in cases versus 44.7 ± 3.5 fL in controls, with significant correlation to GRACE score and inverse correlation to left ventricular ejection fraction 5
  • Sex-specific differences: RDW-SD and transfusions predict 2-year mortality after TAVI in males but not females, highlighting important biological differences 6
  • Dilated cardiomyopathy: In patients with pre-diabetes or diabetes, RDW-SD shows adjusted HR of 1.48 and 1.30 per SD increase respectively, though not significant in normoglycemic patients 7

Critical Illness and Mortality

  • COVID-19: RDW-SD demonstrated an AUC of 0.870 for predicting severe disease prognosis, with cut-off of 42.15 fL yielding 73.1% sensitivity and 80.2% specificity 4
  • General population: Elevated RDW serves as a strong independent risk factor for death across diverse populations 1

Nutritional Status

  • Malnutrition marker: High RDW (≥15%) associates with 48% increased odds of malnutrition risk [OR 1.48] and doubles 30-day mortality risk [adjusted HR 2.12] in hospitalized patients 8
  • Treatment response: Patients with elevated baseline RDW show stronger benefit from nutritional interventions, with adjusted OR 0.56 for 30-day mortality reduction 8

What Abnormal Results Indicate

Elevated RDW-SD (>42-45 fL) reflects:

  • Impaired erythropoiesis: Disrupted red blood cell production from bone marrow dysfunction 1
  • Metabolic derangement: Oxidative stress, inflammation, poor nutritional status, dyslipidemia, and hypertension 1
  • Shortened telomere length: Cellular aging and dysfunction 1
  • Erythrocyte fragmentation: Mechanical or metabolic damage to circulating red cells 1
  • Altered erythropoietin function: Dysregulation of red cell maturation 1
  • Increased reticulocytes: Elevated young red cells contribute to heterogeneity, as seen in critical COVID-19 patients 4

Clinical Pitfalls and Caveats

  • Not disease-specific: Elevated RDW-SD indicates physiologic derangement but doesn't pinpoint a single etiology 1
  • Demographic variations: Normal ranges may vary by age, sex, and ethnicity, requiring population-specific interpretation 1
  • Storage effects: Unlike hemoglobin, RDW measurements are relatively stable, but pre-analytical variables should be controlled 2
  • Context matters: In chronic kidney disease, evaluate complete blood count abnormalities in multiple cell lines, as this warrants hematology consultation 2
  • Iron status first: In sideroblastic anemia, patients should not be considered pyridoxine-refractory until iron stores are normalized, as iron overload impairs mitochondrial function 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.